Heart Disease News and Research

Latest Heart Disease News and Research

Warner Bros recording artist to donate concert profits to BC Children's Hospital

Warner Bros. recording artist Michael Bublé announced during his August 20 concert in his hometown that all profits from the show would go to BC Children's Hospital Foundation's Campaign for BC Children, a $200-million initiative to support the construction of a new BC Children's Hospital and to enhance medical services for children throughout the province.

21 Aug 2010

Low testosterone levels to blame for low libido, fatigue and weight gain

While most frequently associated with women's health, age-related hormone changes, often dubbed menopause, can occur in men as well, causing symptoms of fatigue, mood swings, decreased desire for sex, hair loss, lack of concentration and weight gain. Experts estimate that more than 5 million men are affected, yet worry the number may be considerably higher since symptoms are frequently ignored.

21 Aug 2010

Scientists identify compound to treat Chagas' disease

A new compound may offer an effective drug candidate against the deadly tropical infection, Chagas' disease say researchers from Brazil. They report their findings in the August 2010 issue of the journal Antimicrobial Agents and Chemotherapy.

21 Aug 2010

What hospital consolidation means for the cost of an MRI

An MRI for a skier's torn ligament at Sutter Davis Hospital near Sacramento cost $1,271, while an identical scan at a nearby imaging center run by Radiological Associates of Sacramento runs only $696, Bloomberg reports. Why? Insurers say it's because Sutter has monopolized the regional hospital market and can essentially demand whatever prices it wants — often between 40 and 70 percent higher than competitors.

21 Aug 2010

Female sexual offenders often unrecognised and underreported

Sexual offenses committed by women, while often unrecognised and underreported, have become the subject of a new book by a University of Montreal professor. Female Sexual Offenders: Theory, Assessment and Treatment (Wiley), is the first volume of its kind to provide an overview of female-perpetrated sexual abuse, statistics on the crime, as well as treatment options for offenders.

21 Aug 2010

ASIR coronary CTA technique reduces radiation dose by 27%

A new low-dose coronary computed tomography angiography (CTA) technique called adaptive statistical iterative reconstruction (ASIR) can reduce the radiation dose associated with coronary CTA by 27 percent, according to a study in the September issue of the American Journal of Roentgenology (www.ajronline.org). Coronary CTA is a common heart imaging test that helps determine if fatty or calcium deposits have narrowed a patient's coronary arteries.

21 Aug 2010

Report says developing countries remain unprepared for cancer prevention, diagnosis, treatment

"Developing countries will bear 60 percent of the world's cancer burden by 2020 and 70 percent by 2030," according to a report released Thursday during the World Cancer Congress in Shenzhen, China, Reuters reports. These countries also lack the necessary "infrastructure … to prevent cancer, diagnose it early or provide long-term treatment, according to CanTreat International, which comprises experts from leading international cancer organizations," the news service writes.

20 Aug 2010

HealthPartners receives grant to study primary care clinics' transformation to health care homes

The HealthPartners Research Foundation has received an US Department of Health & Human Services Agency for Healthcare Research and Quality grant to study the transformation of traditional primary care clinics in Minnesota to "health care homes," also known as "medical homes."

20 Aug 2010

Study links obesity rates with walking and cycling rates

A study authored by Professor David Bassett Jr. from the Department of Kinesiology, Recreation and Sport Studies at the University of Tennessee, Knoxville, and three other researchers was published in the American Journal of Public Health, concluding that communities with more walkers and cyclists are healthier than those where people must rely on cars to get around.

20 Aug 2010

NIAID's renewed 'Centers for Countermeasures Against Radiation' program to support research at 7 institutions

A major research effort to develop medical products to diagnose, prevent and treat the short- and long-term consequences of radiation exposure after a radiological or nuclear terrorist attack has been renewed by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health.

20 Aug 2010

NSF issues award to develop techniques for analyzing children's behavior

A team led by the Georgia Institute of Technology has received a $10 million "Expeditions in Computing" award from the National Science Foundation (NSF) to develop novel computing techniques for measuring and analyzing the behavior of children.

20 Aug 2010

Tasigna receives approval for chronic myeloid leukemia in Canada

Tasigna (nilotinib) capsules have been approved with conditions in Canada as a new therapy for patients with CML, in the chronic phase (first phase) of the disease. Patients must be resistant to or intolerant of at least one prior therapy, including (Pr)Gleevec (imatinib mesylate), an established standard of care.

20 Aug 2010

Cedars-Sinai opens Advanced Heart Failure Unit in California

The Cedars-Sinai Heart Institute has opened an innovative 30-bed in-patient unit dedicated to providing advanced heart failure patients with an intensive, multidisciplinary approach to inpatient care.

20 Aug 2010

Experts discuss role of technology and innovation in healthcare industry

Leaders from healthcare, technology companies and academia will meet on Tuesday, Aug. 24, for a day-long session in the Chippewa Valley technology corridor. Participants will discuss how the use of technology and innovation can help overcome some of the biggest challenges facing the healthcare industry.

20 Aug 2010

Ohio appeals court reinstates claim that diet drug Redux should not have been marketed

An Ohio Federal Court of Appeals ruling issued yesterday is reinstating the late victim's claim that the recalled diet drug Redux (commonly called fen-phen) linked to her death should never have been marketed to the American people by Wyeth due in part to its pre-approval concerns about potentially lethal side effects.

20 Aug 2010

Cancer patients may live longer with palliative and hospice care services: Study

A new study released by the New England Journal of Medicine found that among patients with non-small-cell lung cancer, those who received palliative care lived, on average, almost two months longer than those who received standard care. Researchers also found that the patients receiving palliative care reported a higher quality of life through the final course of their illness.

20 Aug 2010

St. Vincent's Hospital performs Australia's first implant of SynCardia temporary Total Artificial Heart

On Aug. 5, St. Vincent's Hospital in Sydney performed Australia's first implant of the SynCardia temporary Total Artificial Heart. The patient, a 50-year-old male suffering from total heart failure, is the first recipient of the Total Artificial Heart in the Southern Hemisphere. The surgery was performed by heart surgeons Drs. Phillip Spratt and Paul Jansz.

20 Aug 2010

Genetic architecture controlling growth of 'back-up' blood vessels uncovered

Researchers at the University of North Carolina at Chapel Hill School of Medicine have uncovered the genetic architecture controlling the growth of the collateral circulation - the "back-up" blood vessels that can provide oxygen to starved tissues in the event of a heart attack or stroke.

20 Aug 2010

Positron signs agreement with Covidien for automated compounding of radiopharmaceuticals

Positron Corporation, announced it has signed an agreement with Covidien, a leading global provider of healthcare products, under which Covidien will provide technical assistance to Positron in connection with Positron's development of technology to automate the compounding of radiopharmaceuticals.

20 Aug 2010

Quark Pharmaceuticals announces option agreement with Novartis for QPI-1002 siRNA drug

Silence Therapeutics plc, a leading international RNAi therapeutics company, is pleased to note that its partner, Quark Pharmaceuticals, Inc., has announced the grant of an option to Novartis to obtain an exclusive worldwide license to develop and commercialise QPI-1002, a p53 temporary inhibitor siRNA drug which incorporates Silence's AtuRNAi technology.

20 Aug 2010

Heart Disease News and Research

Latest Heart Disease News and Research

Warner Bros recording artist to donate concert profits to BC Children's Hospital

Low testosterone levels to blame for low libido, fatigue and weight gain

Scientists identify compound to treat Chagas' disease

What hospital consolidation means for the cost of an MRI

Female sexual offenders often unrecognised and underreported

ASIR coronary CTA technique reduces radiation dose by 27%

Report says developing countries remain unprepared for cancer prevention, diagnosis, treatment

HealthPartners receives grant to study primary care clinics' transformation to health care homes

Study links obesity rates with walking and cycling rates

NIAID's renewed 'Centers for Countermeasures Against Radiation' program to support research at 7 institutions

NSF issues award to develop techniques for analyzing children's behavior

Tasigna receives approval for chronic myeloid leukemia in Canada

Cedars-Sinai opens Advanced Heart Failure Unit in California

Experts discuss role of technology and innovation in healthcare industry

Ohio appeals court reinstates claim that diet drug Redux should not have been marketed

Cancer patients may live longer with palliative and hospice care services: Study

St. Vincent's Hospital performs Australia's first implant of SynCardia temporary Total Artificial Heart

Genetic architecture controlling growth of 'back-up' blood vessels uncovered

Positron signs agreement with Covidien for automated compounding of radiopharmaceuticals

Quark Pharmaceuticals announces option agreement with Novartis for QPI-1002 siRNA drug

Todd Bauman and Chris Povich

Scaling organ‑chip technology for human‑relevant drug discovery

Unlocking drug amorphization: Continuous, solvent-free twin screw granulation

Heart Disease News and Research

Latest Heart Disease News and Research

Todd Bauman and Chris Povich

Scaling organ‑chip technology for human‑relevant drug discovery

Unlocking drug amorphization: Continuous, solvent-free twin screw granulation

Newsletters you may be interested in